Wed, November 27, 2024
[ Wed, Nov 27th 2024 ]: Thomas Matters
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
[ Wed, Nov 27th 2024 ]: Thomas Matters
JPMorgan Sees US Equities Extending Global Dominance in 2025
[ Wed, Nov 27th 2024 ]: Thomas Matters
NTPC Green Energy Share Price Highlights: Stock e .. at 2.25 apiece on NSE, 2.27% premium to IPO price
[ Wed, Nov 27th 2024 ]: Thomas Matters
Money blog: Halifax goes rogue with new mortgage term
[ Wed, Nov 27th 2024 ]: Thomas Matters
Donald Trump Assumes Office in Fewer Than 60 Days .. vestors Expect Something Big From These 3 Stocks.
[ Wed, Nov 27th 2024 ]: Thomas Matters
Want $97 in Super-Safe Monthly Dividend Income? Invest $5,000 in These 3 Ultra-High-Yield Stocks
[ Wed, Nov 27th 2024 ]: Thomas Matters
Billionaire Warren Buffett Has Invested $9 Billion (at Cost) in These 2 Unstoppable Stocks
[ Wed, Nov 27th 2024 ]: Thomas Matters
Americans' stock-market optimism hits record high. But there are risks.
[ Wed, Nov 27th 2024 ]: Thomas Matters
Is Nvidia Still the Best Artificial Intelligence (AI) Stock to Own for 2025?
[ Wed, Nov 27th 2024 ]: Thomas Matters
JPMorgan Strategists See US Equities Extending Global Dominance
[ Wed, Nov 27th 2024 ]: Thomas Matters
Plug Power Highlights Green Hydrogen at Energy Conference
[ Wed, Nov 27th 2024 ]: Thomas Matters
The Best Small-Cap ETF to Buy Right Now (and One Intriguing Alternative)
[ Wed, Nov 27th 2024 ]: Thomas Matters
Money blog: World's most beautiful airports named
[ Wed, Nov 27th 2024 ]: Thomas Matters
Stocks rise Tuesday, Dow and S&P 500 close at records: Live updates
[ Wed, Nov 27th 2024 ]: Thomas Matters
Why we're continuing to add stocks and credit to portfolios in 2025
[ Wed, Nov 27th 2024 ]: Thomas Matters
Invesco American Franchise Fund Q3 2024 Commentary
[ Wed, Nov 27th 2024 ]: Thomas Matters
The Smartest Growth Stock to Buy With $3,000 Right Now
[ Wed, Nov 27th 2024 ]: Thomas Matters
E-Commerce Growth Is Back: 2 Smart Stocks to Buy
[ Wed, Nov 27th 2024 ]: Thomas Matters
FTSE 00 LIVE: Stocks slip as traders await US inflation data and mull Trump tariffs
[ Wed, Nov 27th 2024 ]: Thomas Matters
Four high-yield, high-promise small caps
[ Wed, Nov 27th 2024 ]: Thomas Matters
European Stocks Drop With Focus on ECB Rates, Trump Appointments
[ Wed, Nov 27th 2024 ]: Thomas Matters
Cathie Wood dumps millions of Palantir and Tesla stock; Here's what she bought
[ Wed, Nov 27th 2024 ]: Thomas Matters
Modi Wins Key State Elections, Instilling Confidence In The Indian Stock Market
[ Wed, Nov 27th 2024 ]: Thomas Matters
Money blog: UK pension scheme called 'deeply irresponsible' after investing in Bitcoin
[ Wed, Nov 27th 2024 ]: Thomas Matters
Tesla Stock And Trump: Risks Galore
[ Wed, Nov 27th 2024 ]: Thomas Matters
Money blog: UK pension scheme slammed for being 'deeply irresponsible' after investing in Bitcoin
[ Wed, Nov 27th 2024 ]: Thomas Matters
Stock market today: Wall Street hangs near its records despite tariff talk
[ Wed, Nov 27th 2024 ]: Thomas Matters
Investors cling to crash protection despite sizzling US stock market rally
[ Wed, Nov 27th 2024 ]: Thomas Matters
Stock market today: Wall Street hits records despite tariff talk
[ Wed, Nov 27th 2024 ]: Thomas Matters
Nvidia Aside: Top 5 AI Stocks to Buy in 2024 and Why
[ Wed, Nov 27th 2024 ]: Thomas Matters
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
Tue, November 26, 2024
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stocks Settle Higher on Positive Corporate News and Reduced Geopolitical Risks
[ Tue, Nov 26th 2024 ]: Thomas Matters
3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
[ Tue, Nov 26th 2024 ]: Thomas Matters
Analysts Bullish on Reliance Comeback While Adani Stocks Remain Under Scrutiny
[ Tue, Nov 26th 2024 ]: Thomas Matters
HKDPB announces key findings of "Hongkongers' Sen .. Savings" Survey for the seventh consecutive year
[ Tue, Nov 26th 2024 ]: Thomas Matters
Enviro Infra Engineers IPO allotment likely today .. Check status, GMP, listing date and other details
[ Tue, Nov 26th 2024 ]: Thomas Matters
Nifty may retest its all-time high level. 3 stocks to lead the rally
[ Tue, Nov 26th 2024 ]: Thomas Matters
How to Invest in Intuitive Machines (LUNR)
[ Tue, Nov 26th 2024 ]: Thomas Matters
Trump Heralds Unease in Global Halls of Power With Tariff Threat
[ Tue, Nov 26th 2024 ]: Thomas Matters
2 No-Brainer Semiconductor Stocks to Buy Right Now
[ Tue, Nov 26th 2024 ]: Thomas Matters
Core portfolio with US equities could mitigate impact of looming 'seismic changes'
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stock market today: S&P 500, Dow end at record as .. estors shake off tariff fears, digest Fed minutes
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stock futures are little changed as Wall Street a .. s Fed's preferred inflation reading: Live updates
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stock Market Today: The S&P 500 Reclaims the 6K Level
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stock Market Today: Dow, S&P 500 end at records a .. inutes as investors shake off Trump tariff pledge
[ Tue, Nov 26th 2024 ]: Thomas Matters
Singapore-listed Dow ETF offers local investors a gateway to US stocks, say panellists
[ Tue, Nov 26th 2024 ]: Thomas Matters
Couche-Tard confident in persistent but friendly approach to bid for 7-Eleven owner
[ Tue, Nov 26th 2024 ]: Thomas Matters
Stock Market Highlights: Nifty short-term trend r .. trong resistance at 24,350. How to trade tomorrow

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

The article from MSN Money discusses why Catalyst Pharmaceutical (CPRX) is considered a strong momentum stock. It highlights that CPRX has shown significant positive momentum in its stock price, with a 1.86% increase last week, outperforming the Zacks Medical - Drugs industry which saw a 0.35% rise. Over longer periods, CPRX has also performed well, with a 13.86% increase in the last quarter and a 110.75% rise over the past year, compared to the S&P 500's 10.16% and 27.47% respectively. The stock's momentum is further supported by positive earnings estimate revisions; over the past two months, the consensus estimate for the full year has increased from $1.11 to $1.46. This upward trend in earnings estimates, combined with strong stock price performance, has led to CPRX receiving a Momentum Style Score of A and a Zacks Rank of #2 (Buy), making it an attractive option for investors looking for momentum stocks.

Read the Full MSN Article at [ https://www.msn.com/en-us/money/topstocks/here-s-why-catalyst-pharmaceutical-cprx-is-a-strong-momentum-stock/ar-AA1uRvLS ]